Harpoon Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 77
Employees
  • Stock Symbol
  • HARP
Stock Symbol
  • Share Price
  • $23.40
  • (As of Friday Closing)

Harpoon Therapeutics General Information

Description

Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 4000 Shoreline Court
  • Suite 250
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Harpoon Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Harpoon Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$23.40 $21.36 $10.27 - $25.02 $754M 32.2M 208K -$2.13

Harpoon Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 269,908 258,213
Revenue 12,186 5,777 4,750 708
EBITDA (52,605) (57,348) (27,117) (16,257)
Net Income (52,819) (55,572) (27,366) (16,830)
Total Assets 183,321 176,604 102,580 31,872
Total Debt 14,053 14,944 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Harpoon Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Harpoon Therapeutics‘s full profile, request access.

Request a free trial

Harpoon Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Harpoon Therapeutics‘s full profile, request access.

Request a free trial

Harpoon Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell
Biotechnology
South San Francisco, CA
77 As of 2020
00000
0000 0000-00-00
00000000 00000

0000000

tion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000 000000000
San Diego, CA
000 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

iqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commo
0000 000000000
San Carlos, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Harpoon Therapeutics Competitors (38)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Poseida Therapeutics Formerly VC-backed San Diego, CA 000 00000 00000000 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
000000 00000000000 Formerly VC-backed Burlingame, CA 00 00000 00000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00
You’re viewing 5 of 38 competitors. Get the full list »

Harpoon Therapeutics Executive Team (8)

Name Title Board Seat Contact Info
Gerald McMahon Ph.D Chief Executive Officer & Board Member
Georgia Erbez Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Holger Wesche Chief Scientific Officer
Che-Leung Law Ph.D Vice President of Translational Medicine
Karin Thacker Vice President, Regulatory Affairs and Quality Assurance
You’re viewing 5 of 8 executive team members. Get the full list »

Harpoon Therapeutics Board Members (13)

Name Representing Role Since
Andrew Robbins Harpoon Therapeutics Board Member 000 0000
Gerald McMahon Ph.D Harpoon Therapeutics Chief Executive Officer & Board Member 000 0000
Jo Viney Ph.D Self Board Member 000 0000
Jonathan Drachman MD Self Board Member 000 0000
Joseph Bailes Harpoon Therapeutics Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Harpoon Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Harpoon Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Harpoon Therapeutics‘s full profile, request access.

Request a free trial